Review on triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention
10.13699/j.cnki.1001-6821.2017.12.024
- VernacularTitle:心房颤动患者经皮冠状动脉介入治疗术后三联抗栓治疗的研究进展
- Author:
Wen-Yu LIU
1
;
Jing-Jing YU
;
Chuan-Pin CHEN
;
Guo-Ping YANG
Author Information
1. 中南大学湘雅药学院
- Keywords:
triple antithrombotic therapy;
atrial fibrillation;
percutaneous coronary intervention;
anticoagulation
- From:
The Chinese Journal of Clinical Pharmacology
2017;33(12):1161-1164
- CountryChina
- Language:Chinese
-
Abstract:
A third of patients with atrial fibrillation (AF)complicated coronary heart disease (CHD),most of them need to take triple antithrombotic therapy after undergoingpercutaneous coronary intervention.However,this treatment has a higher risk of bleeding.This review summarizes the recent researches on triple antithrombotic therapy,and hopes to provide a reference forclinical practice.
